174 related articles for article (PubMed ID: 32209188)
21. Apatinib affect VEGF-mediated cell proliferation, migration, invasion via blocking VEGFR2/RAF/MEK/ERK and PI3K/AKT pathways in cholangiocarcinoma cell.
Huang M; Huang B; Li G; Zeng S
BMC Gastroenterol; 2018 Nov; 18(1):169. PubMed ID: 30400838
[TBL] [Abstract][Full Text] [Related]
22. Increased insulin-like growth factor 1 receptor (IGF1R) expression in small cell lung cancer and the effect of inhibition of IGF1R expression by RNAi on growth of human small cell lung cancer NCI-H446 cell.
Wang Z; Lu P; Liang Z; Zhang Z; Shi W; Cai X; Chen C
Growth Factors; 2015; 33(5-6):337-46. PubMed ID: 26430715
[TBL] [Abstract][Full Text] [Related]
23. [Effect of FGF-2 on survivin and subcellular location of Smac in human small cell lung cancer cell NCI-H446].
Xiao DS; Cao HQ; Deng ZH; Qu XH; Wen JF; Zhou JH; Fu CY
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Aug; 33(8):705-11. PubMed ID: 18772510
[TBL] [Abstract][Full Text] [Related]
24. [CIAPIN1 expression in human lung cancer tissues and inhibitory effects of the gene on human pulmonary carcinoma NCI-H446 cells].
Wang Y; Qi HW; Li XH; Chen XX; Liu J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 May; 24(5):434-7. PubMed ID: 18466694
[TBL] [Abstract][Full Text] [Related]
25. In vivo and in vitro inhibition of SCLC by combining dual cancer-specific recombinant adenovirus with Etoposide.
Li T; Fang J; Chu J; Liu X; Li Y; Zhu Y; Li S; Xiu Z; Li Y; Jin N; Zhu G; Sun L; Li X
J Cancer Res Clin Oncol; 2022 May; 148(5):1073-1085. PubMed ID: 35038020
[TBL] [Abstract][Full Text] [Related]
26. The apatinib inhibits breast cancer cell line MDA-MB-231 in vitro by inducing apoptosis, cell cycle arrest, and regulating nuclear factor-κB (NF-κB) and mitogen-activated protein kinase (MAPK) signaling pathways.
Maroufi NF; Vahedian V; Akbarzadeh M; Mohammadian M; Zahedi M; Isazadeh A; Pouremamali F; Taefehshokr S; Heidari M; Rashidi M; Nouri M
Breast Cancer; 2020 Jul; 27(4):613-620. PubMed ID: 32026267
[TBL] [Abstract][Full Text] [Related]
27. Apatinib inhibits glycolysis by suppressing the VEGFR2/AKT1/SOX5/GLUT4 signaling pathway in ovarian cancer cells.
Chen L; Cheng X; Tu W; Qi Z; Li H; Liu F; Yang Y; Zhang Z; Wang Z
Cell Oncol (Dordr); 2019 Oct; 42(5):679-690. PubMed ID: 31325096
[TBL] [Abstract][Full Text] [Related]
28. [Molecular mechanism of anti-apoptotic action of survivin in NCI-H446 lung cancer cells].
Chen Y; Li W; Zhou JH; Li DM; Xia XM; Huang LN; Li BQ
Zhonghua Zhong Liu Za Zhi; 2006 Jun; 28(6):413-7. PubMed ID: 17152484
[TBL] [Abstract][Full Text] [Related]
29. Apatinib exerts anti-tumour effects on ovarian cancer cells.
Ding J; Cheng XY; Liu S; Ji HY; Lin M; Ma R; Meng FL
Gynecol Oncol; 2019 Apr; 153(1):165-174. PubMed ID: 30651189
[TBL] [Abstract][Full Text] [Related]
30. Quinalizarin, a specific CK2 inhibitor, reduces cell viability and suppresses migration and accelerates apoptosis in different human lung cancer cell lines.
Zhou Y; Li K; Zhang S; Li Q; Li Z; Zhou F; Dong X; Liu L; Wu G; Meng R
Indian J Cancer; 2015 Dec; 52 Suppl 2():e119-24. PubMed ID: 26728669
[TBL] [Abstract][Full Text] [Related]
31. In vitro and in vivo apatinib inhibits vasculogenic mimicry in melanoma MUM-2B cells.
Liu ZJ; Zhou YJ; Ding RL; Xie F; Fu SZ; Wu JB; Yang LL; Wen QL
PLoS One; 2018; 13(7):e0200845. PubMed ID: 30052652
[TBL] [Abstract][Full Text] [Related]
32. [Solasonine-induced Apoptosis in Lung Cancer Cell Line H446 and Its Mechanism].
Huang W; Wang Y; Zhu H; Wu Y; Xie X; Wang D
Zhongguo Fei Ai Za Zhi; 2015 Jul; 18(7):416-21. PubMed ID: 26182866
[TBL] [Abstract][Full Text] [Related]
33. Cisplatin and photodynamic therapy exert synergistic inhibitory effects on small-cell lung cancer cell viability and xenograft tumor growth.
Cheng YS; Peng YB; Yao M; Teng JP; Ni D; Zhu ZJ; Zhuang BF; Yang ZY
Biochem Biophys Res Commun; 2017 Jun; 487(3):567-572. PubMed ID: 28431928
[TBL] [Abstract][Full Text] [Related]
34. Design, synthesis, and biological evaluation of novel 7-substituted 10,11-methylenedioxy-camptothecin derivatives against drug-resistant small-cell lung cancer in vitro and in vivo.
Zhang G; Yin R; Dai X; Wu G; Qi X; Yu R; Li J; Jiang T
Eur J Med Chem; 2022 Nov; 241():114610. PubMed ID: 35932565
[TBL] [Abstract][Full Text] [Related]
35. New application of an old drug: Antitumor activity and mechanisms of doxycycline in small cell lung cancer.
Wang SQ; Zhao BX; Liu Y; Wang YT; Liang QY; Cai Y; Zhang YQ; Yang JH; Song ZH; Li GF
Int J Oncol; 2016 Apr; 48(4):1353-60. PubMed ID: 26846275
[TBL] [Abstract][Full Text] [Related]
36. Experimental study of the vascular normalization window for tumors treated with apatinib and the efficacy of sequential chemotherapy with apatinib in lung cancer-bearing mice and patients.
Liu M; Li H; Wang X; Jing L; Jiang P; Li Y
Cancer Med; 2020 Apr; 9(8):2660-2673. PubMed ID: 32073228
[TBL] [Abstract][Full Text] [Related]
37. Adenovirus-mediated siRNA targeting c-Met inhibits proliferation and invasion of small-cell lung cancer (SCLC) cells.
Wang ZX; Lu BB; Yang JS; Wang KM; De W
J Surg Res; 2011 Nov; 171(1):127-35. PubMed ID: 20338593
[TBL] [Abstract][Full Text] [Related]
38. Apatinib-induced protective autophagy and apoptosis through the AKT-mTOR pathway in anaplastic thyroid cancer.
Feng H; Cheng X; Kuang J; Chen L; Yuen S; Shi M; Liang J; Shen B; Jin Z; Yan J; Qiu W
Cell Death Dis; 2018 Oct; 9(10):1030. PubMed ID: 30301881
[TBL] [Abstract][Full Text] [Related]
39. Brain microvascular endothelium induced-annexin A1 secretion contributes to small cell lung cancer brain metastasis.
Liu Y; Liu YS; Wu PF; Li Q; Dai WM; Yuan S; Xu ZH; Liu TT; Miao ZW; Fang WG; Chen YH; Li B
Int J Biochem Cell Biol; 2015 Sep; 66():11-9. PubMed ID: 26135980
[TBL] [Abstract][Full Text] [Related]
40. Hyperthermia induced HIF-1a expression of lung cancer through AKT and ERK signaling pathways.
Wan J; Wu W
J Exp Clin Cancer Res; 2016 Jul; 35(1):119. PubMed ID: 27456341
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
